You are here

Lixiana

ESC 2022 preview – who’s got the XI factor?

EP Vantage

Tue, 08/23/22 - 10:23 am

Bristol Myers Squibb

Encouraging trial results for Daiichi anti-stroke therapy

The Pharma Letter

Fri, 05/18/18 - 09:41 pm

clinical trials

atrial fibrilation

Daiichi clot-buster wins a NICE green light, but still faces an uphill track

Fierce Biotech

Wed, 08/12/15 - 12:41 pm